Phenominer Database Results (11 results)

 

Table "column sort" updates the order of the bars in the chart.
Strain
Phenotype
Conditions
Study
Experiment Name
Sex
Age
# of Animals
Value
Units
SEM
SD
Method
Method Site
Method Duration
Post Insult Type
Post Insult Time Value
Post Insult Time Unit
Method Notes
Clinical Measurement Notes
Record ID
Study ID
RCS/N scotopic A wave amplitude of ERG waveform gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector (21.6 x 10E8 vg) then controlled exposure to darkness (for 12 hours) then visible light stimulus (2.5 cd x s/m2) Deng WT, et al., Invest Ophthalmol Vis Sci. 2012 Apr 6;53(4):1895-904. doi: 10.1167/iovs.11-8831. rod electrophysiology trait not specified 62 days 6 175.0 uV 14.7 36.0 electroretinography cornea 0.0 AAV8 injection 60 days treated eye scotopic a-wave amplitude ERG 108680 3129
RCS/N scotopic B wave amplitude of ERG waveform gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector (21.6 x 10E8 vg) then controlled exposure to darkness (for 12 hours) then visible light stimulus (2.5 cd x s/m2) Deng WT, et al., Invest Ophthalmol Vis Sci. 2012 Apr 6;53(4):1895-904. doi: 10.1167/iovs.11-8831. rod electrophysiology trait not specified 62 days 6 500.0 uV 61.24 150.0 electroretinography cornea 0.0 AAV8 injection 60 days treated eye scotopic b-wave amplitude ERG 108682 3129
RCS/N photopic B wave amplitude of ERG waveform gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector (21.6 x 10E8 vg) then controlled visible light condition (30 cd/m2) (for 0.1 hours) then visible light stimulus (10 cd x s/m2) and controlled visible light condition (30 cd/m2) Deng WT, et al., Invest Ophthalmol Vis Sci. 2012 Apr 6;53(4):1895-904. doi: 10.1167/iovs.11-8831. cone electrophysiology trait not specified 242 days 4 30.0 uV 5.5 11.0 electroretinography cornea 0.0 AAV8 injection 240 days treated eye photopic b-wave amplitude ERG 108685 3129
RCS/N photopic B wave amplitude of ERG waveform lensotomy then controlled visible light exposure (for 0.2 hours) then visible light stimulus (100 cd x s/m2) Heiduschka P, et al., ISRN Ophthalmol. 2013 Sep 19;2013:814814. doi: 10.1155/2013/814814. eCollection 2013. cone electrophysiology trait not specified 60 days 3 13.7 uV 2.19 3.8 electroretinography cornea 0.0 lens puncture 30 days photopic b-wave ERG 108569 3124
RCS/N ERG oscillatory potential lensotomy then controlled exposure to darkness (for 1 days) then visible light stimulus (100 cd x s/m2) Heiduschka P, et al., ISRN Ophthalmol. 2013 Sep 19;2013:814814. doi: 10.1155/2013/814814. eCollection 2013. eye electrophysiology trait not specified 60 days 3 67.6 uV 16.69 28.9 electroretinography cornea 0.0 lens puncture 30 days scotopic ocillatory index ERG 108568 3124
RCS/N scotopic A wave amplitude of ERG waveform control condition then controlled exposure to darkness (for 12 hours) then visible light stimulus (2.5 cd x s/m2) Deng WT, et al., Invest Ophthalmol Vis Sci. 2012 Apr 6;53(4):1895-904. doi: 10.1167/iovs.11-8831. rod electrophysiology trait not specified 62 days 6 16.0 uV 6.94 17.0 electroretinography cornea 0.0 AAV8 injection 60 days contralateral control eye scotopic a-wave amplitude ERG 108681 3129
RCS/N scotopic B wave amplitude of ERG waveform gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector (21.6 x 10E8 vg) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.01 cd x s/m2) Deng WT, et al., Invest Ophthalmol Vis Sci. 2012 Apr 6;53(4):1895-904. doi: 10.1167/iovs.11-8831. rod electrophysiology trait not specified 242 days 4 223.0 uV 28.0 56.0 electroretinography cornea 0.0 AAV8 injection 240 days treated eye scotopic b-wave amplitude ERG 108684 3129
RCS/N scotopic A wave amplitude of ERG waveform lensotomy then controlled exposure to darkness (for 1 days) then visible light stimulus (100 cd x s/m2) Heiduschka P, et al., ISRN Ophthalmol. 2013 Sep 19;2013:814814. doi: 10.1155/2013/814814. eCollection 2013. rod electrophysiology trait not specified 60 days 3 18.3 uV 4.79 8.3 electroretinography cornea 0.0 lens puncture 30 days scotopic a-wave ERG 108566 3124
RCS/N ERG oscillatory potential lensotomy then controlled visible light exposure (for 0.2 hours) then visible light stimulus (100 cd x s/m2) Heiduschka P, et al., ISRN Ophthalmol. 2013 Sep 19;2013:814814. doi: 10.1155/2013/814814. eCollection 2013. eye electrophysiology trait not specified 60 days 3 33.1 uV 2.19 3.8 electroretinography cornea 0.0 lens puncture 30 days photopic ocillatory index 108570 3124
RCS/N scotopic B wave amplitude of ERG waveform control condition then controlled exposure to darkness (for 12 hours) then visible light stimulus (2.5 cd x s/m2) Deng WT, et al., Invest Ophthalmol Vis Sci. 2012 Apr 6;53(4):1895-904. doi: 10.1167/iovs.11-8831. rod electrophysiology trait not specified 62 days 6 61.0 uV 19.6 48.0 electroretinography cornea 0.0 AAV8 injection 60 days contralateral control eye scotopic b-wave amplitude ERG 108683 3129
RCS/N scotopic B wave amplitude of ERG waveform lensotomy then controlled exposure to darkness (for 1 days) then visible light stimulus (100 cd x s/m2) Heiduschka P, et al., ISRN Ophthalmol. 2013 Sep 19;2013:814814. doi: 10.1155/2013/814814. eCollection 2013. rod electrophysiology trait not specified 60 days 3 30.5 uV 7.51 13.0 electroretinography cornea 0.0 lens puncture 30 days scotopic b-wave ERG 108567 3124